BanerjeeASudlowCLawlerM.Indirect effects of the pandemic: highlighting the need for data-driven policy and preparedness. J R Soc Med2022;115(7):249-51.
2.
WathesRMalhotraKFlottKNathAUrchC.Towards a standardised method of patient prioritisation that accounts for clinical harm. Future Healthc J2021;8(1):e42-6.
3.
TinajeroMGMalikVS.An update on the epidemiology of type 2 diabetes: a global perspective. Endocrinol Metab Clin North Am. 2021;50(3):337-55.
4.
Pop-BusuiRJanuzziJLBruemmerD, et al. Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association. Diabetes Care2022;45(7):1670-90. doi:10.2337/dci22-0014
5.
FalconerNNandSLiowDJacksonASeddonM.Development of an electronic patient prioritization tool for clinical pharmacist interventions. Am J Health Syst Pharm2014;71(4):311-20. doi:10.2146/ajhp130247
6.
KarallieddeJFrenchOBurnhillG, et al. A pragmatic digital health informatics based approach for aiding clinical prioritisation and reducing backlog of care: a study in cohort of 4022 people with diabetes. Diabetes Res Clin Pract2023;203:110834. doi:10.1016/j.diabres.2023.110834
BonnerupDKLisbyMSædderEA, et al. Effects of stratified medication review in high-risk patients at admission to hospital: a randomised controlled trial. Ther Adv Drug Saf2020;11:2042098620957142. doi:10.1177/2042098620957142.
10.
ClarkeRColleranMMelanophyGBerminghamM.Enhancing the clinical pharmacy service of a large teaching hospital: development of a new clinical prioritisation tool. Explor Res Clin Soc Pharm. 2023;12:100335. doi:10.1016/j.rcsop.2023.100335
